How AI Can Help Reduce Vaccine R&D From A Year To ‘A Matter Of Weeks’
From rapidly identifying antigenic targets to automating clinical trials, AI has an important role to play in cutting vaccine development time down to 100 days, says Melanie Saville, executive director of R&D at CEPI.
